| Literature DB >> 34397892 |
Soo Kang1, Tae Kyu Ahn1, Young Ho Seo1, Young Ju Suh2, Jin Hui Paik1.
Abstract
ABSTRACT: Infectious disease pandemics has a great impact on the use of medical facilities. The purpose of this study was to analyze the effects of coronavirus disease 2019 (COVID-19) on the use of emergency medical facilities in the Republic of Korea. This single-center, retrospective observational study was conducted in a tertiary teaching hospital located in Incheon Metropolitan City, Republic of Korea. We set the pandemic period as February 19, 2020 to April 18, 2020, and the control period was set to the same period in 2018 and 2019. All consecutive patients who visited the emergency department (ED) during the study period were included. Patients were divided into 3 groups according to age (pediatric patients, younger adult patients and older adult patients). The total number, demographics, clinical data, and diagnostic codes of ED patients were analyzed. The total number of ED patients in the pandemic period was lower than that in the control period, which was particularly pronounced for pediatric patients. The proportion of patients who used the 119 ambulances increased in all 3 groups (P = .002, P < .001, and P = .001), whereas the proportion of patients who visited on foot was decreased (P = .006, P < .001, and P = .027). In terms of diagnostic codes, a significant decrease was observed in the proportion of certain infectious or parasitic diseases (A00-B99), and respiratory diseases (J00-J99) in the pediatric and younger adult patient groups (P < .001 and P < .001, respectively). The COVID-19 pandemic reduced the number of ED patients; however, the proportion of patients using ambulances increased. In particular, the proportion of patients with diagnostic codes for infectious and respiratory diseases significantly decreased during the pandemic period.Entities:
Mesh:
Year: 2021 PMID: 34397892 PMCID: PMC8360451 DOI: 10.1097/MD.0000000000026847
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Flow chart and diagrams of emergency department patients in 2018, 2019 and 2020.
Total number of emergency department patients during the control and pandemic periods.
| Classification | Control period∗ (n = 17,969) | Pandemic period† (n = 7319) | |
| Pediatric patients (<15 years old) | 5172 (28.78) | 1422 (19.43) | <.001 |
| Younger adult patients (15–60 years old) | 8397 (46.73) | 3742 (51.13) | <.001 |
| Older adult patients (>60 years old) | 4400 (24.49) | 2155 (29.44) | <.001 |
Demographic and clinical characteristics of pediatric patients during the control and pandemic periods.
| Variables | Control period∗ (n = 5172) | Pandemic period† (n = 1422) | |
| Age | 3.64 ± 3.63 | 3.66 ± 3.71 | .822 |
| Male | 2886 (55.80) | 799 (56.19) | .794 |
| Patient acuity | <.001 | ||
| High acuity (KTAS 1, 2, 3) | 1773 (34.28) | 368 (25.88) | |
| Low acuity (KTAS 4, 5) | 3399 (65.72) | 1054 (74.12) | |
| Reason for visit | <.001 | ||
| Disease | 3585 (69.32) | 773 (54.36) | |
| Trauma | 1587 (30.68) | 649 (45.64) | |
| Means of visit | .003 | ||
| 119 ambulances | 330 (6.38) | 127 (8.93) | .002‡ |
| Other ambulances | 30 (0.58) | 6 (0.42) | .794‡ |
| On foot | 4812 (93.04) | 1289 (90.65) | .006‡ |
| Transfer-in | 550 (10.63) | 151 (10.62) | .987 |
| Outcome | .023 | ||
| Discharge | 4457 (86.18) | 1223 (86.01) | |
| Admission to ward | 664 (12.84) | 172 (12.10) | |
| Admission to ICU | 28 (0.54) | 12 (0.84) | |
| Transfer-out | 21 (0.41) | 15 (1.05) | |
| Death in ED | 2 (0.04) | 0 (0) | |
| EDLOS, min | 124 (67–188) | 109 (53–178) | <.001 |
Demographic and clinical characteristics of younger adult patients during the control and pandemic periods.
| Variables | Control period∗ (n = 8397) | Pandemic period† (n = 3742) | |
| Age | 38.83 ± 13.16 | 39.54 ± 12.61 | .005 |
| Male | 4380 (52.16) | 1989 (53.15) | .312 |
| Patient acuity | .378 | ||
| High acuity (KTAS 1, 2, 3) | 3016 (35.92) | 1313 (35.09) | |
| Low acuity (KTAS 4, 5) | 5381 (64.08) | 2429 (64.91) | |
| Reason for visit | .133 | ||
| Disease | 5951 (70.87) | 2702 (72.21) | |
| Trauma | 2446 (29.13) | 1040 (27.79) | |
| Means of visit | <.001 | ||
| 119 ambulances | 1550 (18.46) | 805 (21.51) | <.001‡ |
| Other ambulances | 296 (3.53) | 131 (3.50) | 1.000‡ |
| On foot | 6551 (78.02) | 2806 (74.99) | <.001‡ |
| Transfer-in | 852 (10.15) | 382 (10.21) | .917 |
| Outcome | .727 | ||
| Discharge | 6617 (78.80) | 2982 (79.69) | |
| Admission to ward | 1310 (15.60) | 550 (14.70) | |
| Admission to ICU | 333 (3.97) | 153 (4.09) | |
| Transfer-out | 115 (1.37) | 49 (1.31) | |
| Death in ED | 22 (0.26) | 8 (0.21) | |
| EDLOS, min | 143 (87–219) | 146 (87–228) | .056 |
Demographic and clinical characteristics of older adult patients during the control and pandemic periods.
| Variables | Control period∗ (n = 4400) | Pandemic period† (n = 2155) | |
| Age | 73.62 ± 8.55 | 74.04 ± 8.78 | .065 |
| Male | 2249 (51.11) | 1141 (52.95) | .163 |
| Patient acuity | .997 | ||
| High acuity (KTAS 1, 2, 3) | 2973 (67.57) | 1456 (67.56) | |
| Low acuity (KTAS 4, 5) | 1427 (32.43) | 699 (32.44) | |
| Reason for visit | .997 | ||
| Disease | 3626 (82.41) | 1776 (82.41) | |
| Trauma | 774 (17.59) | 379 (17.59) | |
| Means of visit | .002 | ||
| 119 ambulances | 1392 (31.64) | 777 (36.06) | .001‡ |
| Other ambulances | 616 (14.00) | 280 (12.99) | .518‡ |
| On foot | 2392 (54.36) | 1098 (50.95) | .027‡ |
| Transfer-in | 953 (21.66) | 429 (19.91) | 0.102 |
| Outcome | .147 | ||
| Discharge | 8786 (68.66) | 3966 (67.25) | |
| Admission to ward | 2784 (21.76) | 1363 (23.11) | |
| Admission to ICU | 939 (7.34) | 416 (7.05) | |
| Transfer-out | 202 (1.58) | 107 (1.81) | |
| Death in ED | 86 (0.67) | 45 (0.76) | |
| EDLOS, min | 211 (138–306) | 226 (143–328) | .001 |
Diagnostic codes based on Korean Standard Classification of Disease-7 of pediatric patients during the control and pandemic periods.
| Variables | Control period∗ (n = 5172) | Pandemic period† (n = 1422) | |
| Certain infectious and parasitic diseases (A00-B99) | 1535 (29.68) | 286 (20.11) | <.001 |
| Neoplasms (C00-D48) | 6 (0.12) | 1 (0.07) | 1.000 |
| Hematologic diseases (D50-D89) | 13 (0.25) | 3 (0.21) | 1.000 |
| Endocrine and metabolic diseases (E00-E90) | 63 (1.22) | 23 (1.62) | .927 |
| Mental and behavioral disorders (F00-F99) | 1 (0.02) | 1 (0.07) | .994 |
| Neurologic diseases (G00-G99) | 26 (0.50) | 8 (0.56) | 1.000 |
| Cardiac and circulatory diseases (I00-I99) | 29 (0.56) | 6 (0.42) | 1.000 |
| Respiratory diseases (J00-J99) | 752 (14.54) | 59 (4.15) | <.001 |
| Gastrointestinal diseases (K00-K93) | 218 (4.22) | 68 (4.78) | .973 |
| Musculoskeletal diseases (M00-M99) | 32 (0.62) | 16 (1.13) | .416 |
| Trauma and injuries (S00-T98) | 1590 (30.74) | 654 (45.99) | <.001 |
| Others∗∗ | 907 (17.54) | 297 (20.89) | .035 |
Diagnostic codes based on Korean Standard Classification of Disease-7 of younger adult patients during the control and pandemic periods.
| Variables | Control period∗ (n = 8397) | Pandemic period† (n = 3742) | |
| Certain infectious and parasitic diseases (A00-B99) | 688 (8.19) | 186 (4.97) | <.001 |
| Neoplasms (C00-D48) | 148 (1.76) | 74 (1.98) | .997 |
| Hematologic diseases (D50-D89) | 36 (0.43) | 15 (0.40) | 1.000 |
| Endocrine and metabolic diseases (E00-E90) | 84 (1.00) | 40 (1.07) | 1.000 |
| Mental and behavioral disorders (F00-F99) | 186 (2.22) | 91 (2.43) | .999 |
| Neurologic diseases (G00-G99) | 225 (2.68) | 86 (2.30) | .948 |
| Cardiac and circulatory diseases (I00-I99) | 366 (4.36) | 170 (4.54) | 1.000 |
| Respiratory diseases (J00-J99) | 822 (9.79) | 220 (5.88) | <.001 |
| Gastrointestinal diseases (K00-K93) | 894 (10.65) | 382 (10.21) | .999 |
| Musculoskeletal diseases (M00-M99) | 238 (2.83) | 82 (2.19) | .385 |
| Trauma and injuries (S00-T98) | 2443 (29.09) | 1042 (27.85) | .854 |
| Others∗∗ | 2267 (27.00) | 1354 (36.18) | <.001 |
Diagnostic codes based on Korean Standard Classification of Disease-7 of older adult patients during the control and pandemic periods.
| Variables | Control period∗ (n = 4400) | Pandemic period† (n = 2155) | |
| Certain infectious and parasitic diseases (A00-B99) | 211 (4.80) | 82 (3.81) | .272 |
| Neoplasms (C00-D48) | 296 (6.73) | 141 (6.54) | 1.000 |
| Hematologic diseases (D50-D89) | 31 (0.70) | 10 (0.46) | .984 |
| Endocrine and metabolic diseases (E00-E90) | 113 (2.57) | 61 (2.83) | 1.000 |
| Mental and behavioral disorders (F00-F99) | 53 (1.20) | 23 (1.07) | 0.359 |
| Neurologic diseases (G00-G99) | 84 (1.91) | 26 (1.21) | 1.000 |
| Cardiac and circulatory diseases (I00-I99) | 526 (11.95) | 245 (11.37) | 1.000 |
| Respiratory diseases (J00-J99) | 531 (12.07) | 249 (11.55) | 1.000 |
| Gastrointestinal diseases (K00-K93) | 506 (11.50) | 253 (11.74) | 1.000 |
| Musculoskeletal diseases (M00-M99) | 100 (2.27) | 61 (2.83) | .870 |
| Trauma and injuries (S00-T98) | 808 (18.36) | 391 (18.14) | 1.000 |
| Others∗∗ | 1141 (25.93) | 613 (28.45) | .267 |